EGFR and lung carcinoma: The fact that both clonality and actionability of EGFR in the young lung cancer group were higher than those in the old lung cancer group, and the covalent chromatin modification pathway enriched in the young lung cancer group implied the multiple choices of young lung cancer treatment.